BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36952572)

  • 1. Modulating the Kynurenine pathway or sequestering toxic 3-hydroxykynurenine protects the retina from light-induced damage in Drosophila.
    Hebbar S; Traikov S; Hälsig C; Knust E
    PLoS Genet; 2023 Mar; 19(3):e1010644. PubMed ID: 36952572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drosophila eye color mutants as therapeutic tools for Huntington disease.
    Green EW; Campesan S; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
    Fly (Austin); 2012; 6(2):117-20. PubMed ID: 22634544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.
    Campesan S; Green EW; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
    Curr Biol; 2011 Jun; 21(11):961-6. PubMed ID: 21636279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
    Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
    Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
    Front Immunol; 2022; 13():997240. PubMed ID: 36263032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway.
    Zsizsik BK; Hardeland R
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Nov; 133(3):383-92. PubMed ID: 12379423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration.
    Rejdak R; Junemann A; Grieb P; Thaler S; Schuettauf F; Chorągiewicz T; Zarnowski T; Turski WA; Zrenner E
    Pharmacol Rep; 2011; 63(6):1324-34. PubMed ID: 22358081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
    Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
    Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
    Notarangelo FM; Beggiato S; Schwarcz R
    Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.
    Fiedorowicz M; Choragiewicz T; Thaler S; Schuettauf F; Nowakowska D; Wojtunik K; Reibaldi M; Avitabile T; Kocki T; Turski WA; Kaminska A; Grieb P; Zrenner E; Rejdak R; Toro MD
    Front Physiol; 2019; 10():1254. PubMed ID: 31632294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental patterns of 3-hydroxykynurenine accumulation in white and various other eye color mutants of Drosophila melanogaster.
    Howells AJ; Summers KM; Ryall RL
    Biochem Genet; 1977 Dec; 15(11-12):1049-59. PubMed ID: 414739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan Pathway Abnormalities in a Murine Model of Hereditary Glaucoma.
    Fiedorowicz M; Choragiewicz T; Turski WA; Kocki T; Nowakowska D; Wertejuk K; Kamińska A; Avitabile T; Wełniak-Kaminska M; Grieb P; Zweifel S; Rejdak R; Toro MD
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
    Breda C; Sathyasaikumar KV; Sograte Idrissi S; Notarangelo FM; Estranero JG; Moore GG; Green EW; Kyriacou CP; Schwarcz R; Giorgini F
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5435-40. PubMed ID: 27114543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
    Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
    J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila mutants of the kynurenine pathway as a model for ageing studies.
    Savvateeva-Popova EV; Popov AV; Heinemann T; Riederer P
    Adv Exp Med Biol; 2003; 527():713-22. PubMed ID: 15206794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.
    Kocki T; Wnuk S; Kloc R; Kocki J; Owe-Larsson B; Urbanska EM
    J Neural Transm (Vienna); 2012 Feb; 119(2):235-43. PubMed ID: 21660485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons.
    O'Reilly K; O'Farrell K; Midttun O; Rakovets Y; David-Bercholz J; Harkin A
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):679-692. PubMed ID: 33389453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.